搜尋





搜尋





市場行情
/
股票
/
tvrd
/

Tvardi Therapeutics Ord Shs

TVRD

添加自選

2.100USD

0.0000.00%

收盤 07-31 16:00（美東）報價延遲15分鐘

26.23M總市值

0.32本益比TTM

Tvardi Therapeutics Ord Shs

2.100

0.0000.00%

概覽

財務

分析

公司

財務摘要利潤表資產負債表現金流量表

TVRD 利潤表

您可以在這裡找到Tvardi Therapeutics Ord Shs的年度或季度收入報告，以深入了解Tvardi Therapeutics Ord Shs的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

FY2017Q4

FY2017Q3

FY2017Q2

FY2017Q1

FY2016Q4

FY2016Q3

FY2016Q2

FY2016Q1

FY2015Q4

FY2015Q3

FY2015Q2

FY2015Q1

FY2014Q4

FY2014Q3

FY2014Q2

FY2014Q1

FY2013Q4

FY2013Q3

FY2013Q2

FY2012Q4

FY2012Q3

營業總收入

----

20.33%2.57M

-51.56%1.46M

-47.47%2.56M

-85.71%991.00K

-65.37%2.13M

-7.88%3.00M

-55.00%4.87M

-69.86%6.93M

28.71%6.17M

297.20%3.26M

-46.66%10.81M

--23.00M

147.55%4.79M

-99.27%821.00K

118.78%20.27M

-100.00%0.00

-76.09%1.94M

2384.79%112.09M

60.17%9.27M

8.18%5.63M

84.69%8.09M

-18.47%4.51M

14.28%5.79M

81.21%5.21M

--4.38M

--5.53M

--5.06M

--2.87M

-100.00%0.00

--0.00

-100.00%0.00

12914.29%911.00K

--0.00

-100.00%0.00

-90.96%79.00K

-98.57%7.00K

-100.00%0.00

116.89%2.44M

-8.96%874.00K

174.72%489.00K

-6.06%914.00K

10.51%1.13M

-90.37%960.00K

--178.00K

--973.00K

62.36%1.02M

--9.97M

--0.00

--627.00K

營業收入

----

-17.59%1.25M

-100.00%0.00

-72.38%1.30M

-100.00%0.00

-74.97%1.51M

-27.72%2.31M

-56.54%4.70M

-70.40%6.81M

26.10%6.04M

288.43%3.19M

-46.66%10.81M

--23.00M

147.55%4.79M

-99.27%821.00K

118.78%20.27M

-100.00%0.00

-76.09%1.94M

2384.79%112.09M

60.17%9.27M

8.18%5.63M

84.69%8.09M

-18.47%4.51M

14.28%5.79M

81.21%5.21M

--4.38M

--5.53M

--5.06M

--2.87M

-100.00%0.00

--0.00

-100.00%0.00

12914.29%911.00K

--0.00

-100.00%0.00

-90.96%79.00K

-98.57%7.00K

-100.00%0.00

116.89%2.44M

-8.96%874.00K

174.72%489.00K

-6.06%914.00K

10.51%1.13M

-90.37%960.00K

--178.00K

--973.00K

62.36%1.02M

--9.97M

--0.00

--627.00K

主營業務成本

----

-100.00%0.00

----

-100.00%0.00

-76.06%620.00K

-71.46%608.00K

-49.00%1.56M

--1.42M

24.46%2.59M

--2.13M

--3.06M

--0.00

--2.08M

----

營業費用

42.30%7.05M

8.35%7.59M

-24.23%5.94M

-83.15%4.96M

-80.34%7.00M

-76.79%7.84M

-59.98%15.72M

-13.06%29.40M

3.02%35.61M

-2.58%33.76M

42.94%39.27M

3.41%33.81M

0.66%34.57M

61.98%34.66M

-11.02%27.48M

28.26%32.70M

1.61%34.34M

-18.60%21.40M

-2.04%30.88M

-33.07%25.50M

-1.98%33.80M

-34.64%26.29M

7.39%31.52M

38.44%38.09M

25.34%34.48M

57.53%40.22M

41.88%29.35M

60.69%27.52M

88.80%27.51M

97.05%25.53M

114.75%20.69M

-26.30%17.12M

-34.70%14.57M

10.05%12.96M

-28.14%9.63M

111.37%23.24M

129.37%22.32M

58.05%11.77M

102.92%13.40M

111.12%10.99M

85.31%9.73M

-3.61%7.45M

41.40%6.61M

44.68%5.21M

70.57%5.25M

69.51%7.73M

52.98%4.67M

--3.60M

74.00%3.08M

154.41%4.56M

--3.05M

--1.77M

--1.79M

研發費用

1439.50%4.91M

3111.11%5.49M

164.54%3.60M

-98.55%319.00K

-99.40%171.00K

-94.64%1.36M

-69.39%9.27M

-9.68%21.95M

9.20%28.37M

3.09%25.42M

52.36%30.28M

14.42%24.30M

13.95%25.98M

59.28%24.66M

-21.11%19.88M

11.21%21.24M

-15.89%22.80M

-26.41%15.48M

-3.40%25.19M

-43.00%19.10M

-9.14%27.11M

-41.50%21.04M

7.20%26.08M

42.11%33.51M

31.04%29.84M

61.67%35.96M

43.89%24.33M

77.00%23.58M

98.51%22.77M

145.91%22.25M

146.58%16.91M

-35.74%13.32M

-43.43%11.47M

-6.46%9.05M

-36.27%6.86M

142.60%20.73M

167.93%20.28M

73.19%9.67M

129.72%10.76M

152.47%8.55M

118.79%7.57M

-10.05%5.58M

46.38%4.68M

53.79%3.38M

74.87%3.46M

64.93%6.21M

58.34%3.20M

--2.20M

93.35%1.98M

348.10%3.76M

--2.02M

--1.02M

--840.00K

折舊攤銷及損耗

--24.00K

-67.12%24.00K

-100.00%0.00

23.73%73.00K

28.33%77.00K

-27.59%42.00K

34.43%82.00K

-4.84%59.00K

-4.76%60.00K

-7.94%58.00K

-1.61%61.00K

0.00%62.00K

1.61%63.00K

0.00%63.00K

0.00%62.00K

21.57%62.00K

29.17%62.00K

31.25%63.00K

29.17%62.00K

2.00%51.00K

-4.00%48.00K

-7.69%48.00K

-36.71%50.00K

-56.14%50.00K

-60.00%50.00K

-58.40%52.00K

-36.80%79.00K

-7.32%114.00K

2.46%125.00K

5.04%125.00K

28.87%125.00K

-76.30%123.00K

-83.29%122.00K

-54.05%119.00K

-50.00%97.00K

168.91%519.00K

278.24%730.00K

34.20%259.00K

-1.52%194.00K

-1.53%193.00K

-2.03%193.00K

--193.00K

0.00%197.00K

--196.00K

--197.00K

----

--197.00K

----

--198.00K

----

營業利潤

-195.52%-7.05M

-36.78%-7.59M

-12.44%-5.94M

91.25%-2.39M

82.99%-5.55M

81.73%-5.28M

54.47%-14.72M

1.39%-27.27M

-4.15%-32.61M

-21.19%-28.90M

-623.17%-32.34M

0.94%-27.65M

6.61%-31.31M

-2021.44%-23.84M

85.52%-4.47M

-18.46%-27.91M

-142.82%-33.52M

93.40%-1.12M

-19.29%-30.88M

21.47%-23.56M

361.23%78.29M

50.57%-17.02M

-7.22%-25.88M

-29.68%-30.00M

-36.37%-29.97M

-68.23%-34.43M

-35.53%-24.14M

-35.10%-23.13M

-50.83%-21.98M

-57.98%-20.47M

-84.92%-17.81M

23.30%-17.12M

34.70%-14.57M

-10.05%-12.96M

27.71%-9.63M

-103.21%-22.32M

-129.37%-22.32M

-135.04%-11.77M

-132.48%-13.33M

-132.85%-10.99M

-124.38%-9.73M

24.14%-5.01M

-54.42%-5.73M

-37.91%-4.72M

-105.99%-4.34M

-86.47%-6.60M

-153.65%-3.71M

---3.42M

-18.99%-2.10M

-203.95%-3.54M

--6.92M

---1.77M

---1.17M

淨非營業利息收入（費用）

利息收入

-28.82%247.00K

-25.89%312.00K

-46.34%411.00K

-63.55%347.00K

-51.83%421.00K

-11.55%766.00K

-19.98%689.00K

-3.35%952.00K

-9.71%874.00K

30.23%866.00K

223.68%861.00K

508.02%985.00K

591.43%968.00K

499.10%665.00K

103.05%266.00K

-37.69%162.00K

-61.54%140.00K

-70.71%111.00K

-79.34%131.00K

-72.83%260.00K

-69.49%364.00K

-69.94%379.00K

-33.05%634.00K

-12.12%957.00K

--1.19M

--1.26M

--947.00K

--1.09M

----

--22.00K

--13.00K

--14.00K

----

---1.60M

----

特殊收入（費用）

----

100.00%0.00

---330.00K

---6.00M

---4.07M

---2.40M

----

其他非經營性收入（費用）

100.00%0.00

-44.65%-2.87M

-333.94%-2.62M

---1.96M

---1.91M

---1.98M

---604.00K

----

--0.00

稅前利潤

-38.69%-6.80M

9.93%-7.28M

55.70%-5.53M

84.02%-4.91M

75.02%-8.08M

55.49%-12.48M

36.41%-20.02M

-15.12%-30.70M

-6.59%-32.34M

-20.93%-28.03M

-648.43%-31.48M

3.91%-26.66M

9.12%-30.34M

-2188.25%-23.18M

86.32%-4.21M

-19.09%-27.75M

-142.44%-33.38M

93.91%-1.01M

-21.76%-30.75M

19.77%-23.30M

373.32%78.65M

49.83%-16.64M

-8.86%-25.25M

-31.75%-29.04M

-38.50%-28.78M

-70.41%-33.17M

-33.72%-23.20M

-31.12%-22.05M

-46.29%-20.78M

-54.63%-19.47M

-86.48%-17.35M

24.38%-16.81M

35.91%-14.20M

-8.55%-12.59M

29.28%-9.30M

-105.18%-22.23M

-129.01%-22.16M

-132.54%-11.60M

-130.01%-13.15M

-130.38%-10.84M

-124.32%-9.68M

24.18%-4.99M

-56.43%-5.72M

-38.39%-4.70M

-105.82%-4.31M

-43.76%-6.58M

-168.76%-3.66M

---3.40M

-15.99%-2.10M

-290.03%-4.58M

--5.32M

---1.81M

---1.17M

所得稅

----

---398.00K

----

100.00%0.00

-53.61%-255.00K

60.00%-132.00K

22.55%-182.00K

-43.53%-122.00K

-32.80%-166.00K

-400.00%-330.00K

-54.61%-235.00K

-84.78%-85.00K

99.52%-125.00K

54.48%-66.00K

-7500.00%-152.00K

-48.39%-46.00K

-13624.34%-25.94M

-163.64%-145.00K

97.47%-2.00K

78.62%-31.00K

-28.57%-189.00K

72.50%-55.00K

-125.71%-79.00K

-866.67%-145.00K

-3.52%-147.00K

-525.00%-200.00K

-218.18%-35.00K

6.25%-15.00K

-4633.33%-142.00K

---32.00K

45.00%-11.00K

---16.00K

70.00%-3.00K

100.00%0.00

---20.00K

---10.00K

---5.00K

除稅後利潤

-38.69%-6.80M

5.26%-7.28M

55.70%-5.53M

84.02%-4.91M

76.25%-7.68M

55.49%-12.48M

36.41%-20.02M

-15.12%-30.70M

-6.59%-32.34M

-20.93%-28.03M

-648.43%-31.48M

3.91%-26.66M

9.12%-30.34M

-2188.25%-23.18M

86.32%-4.21M

-19.09%-27.75M

-142.30%-33.38M

93.86%-1.01M

-22.65%-30.75M

19.44%-23.30M

375.80%78.91M

49.73%-16.51M

-9.18%-25.07M

-31.70%-28.92M

-38.54%-28.61M

-69.29%-32.84M

-33.53%-22.96M

-30.97%-21.96M

-275.97%-20.65M

-55.90%-19.40M

-84.88%-17.19M

24.49%-16.77M

153.41%11.74M

-7.81%-12.44M

28.87%-9.30M

-107.67%-22.20M

-130.56%-21.97M

-141.11%-11.54M

-130.03%-13.07M

-128.02%-10.69M

-128.43%-9.53M

26.86%-4.79M

-55.94%-5.68M

-38.60%-4.69M

-99.33%-4.17M

-43.06%-6.54M

-168.30%-3.65M

---3.38M

-16.47%-2.09M

-291.70%-4.58M

--5.34M

---1.80M

---1.17M

持續經營利潤

-38.69%-6.80M

5.26%-7.28M

55.70%-5.53M

84.02%-4.91M

76.25%-7.68M

55.49%-12.48M

36.41%-20.02M

-15.12%-30.70M

-6.59%-32.34M

-20.93%-28.03M

-648.43%-31.48M

3.91%-26.66M

9.12%-30.34M

-2188.25%-23.18M

86.32%-4.21M

-19.09%-27.75M

-142.30%-33.38M

93.86%-1.01M

-22.65%-30.75M

19.44%-23.30M

375.80%78.91M

49.73%-16.51M

-9.18%-25.07M

-31.70%-28.92M

-38.54%-28.61M

-69.29%-32.84M

-33.53%-22.96M

-30.97%-21.96M

-275.97%-20.65M

-55.90%-19.40M

-84.88%-17.19M

24.49%-16.77M

153.41%11.74M

-7.81%-12.44M

28.87%-9.30M

-107.67%-22.20M

-130.56%-21.97M

-141.11%-11.54M

-130.03%-13.07M

-128.02%-10.69M

-128.43%-9.53M

26.86%-4.79M

-55.94%-5.68M

-38.60%-4.69M

-99.33%-4.17M

-43.06%-6.54M

-168.30%-3.65M

---3.38M

-16.47%-2.09M

-291.70%-4.58M

--5.34M

---1.80M

---1.17M

反常淨利潤

----

---25.91M

----

歸属于母公司的淨利潤

-38.69%-6.80M

5.26%-7.28M

55.70%-5.53M

84.02%-4.91M

76.25%-7.68M

55.49%-12.48M

36.41%-20.02M

-15.12%-30.70M

-6.59%-32.34M

-20.93%-28.03M

-648.43%-31.48M

3.91%-26.66M

9.12%-30.34M

-2188.25%-23.18M

86.32%-4.21M

-19.09%-27.75M

-142.30%-33.38M

93.86%-1.01M

-22.65%-30.75M

19.44%-23.30M

375.80%78.91M

49.73%-16.51M

-9.18%-25.07M

-31.70%-28.92M

-38.54%-28.61M

-69.29%-32.84M

-33.53%-22.96M

-30.97%-21.96M

-45.67%-20.65M

-55.90%-19.40M

-84.88%-17.19M

24.49%-16.77M

35.48%-14.18M

-7.81%-12.44M

28.87%-9.30M

-107.67%-22.20M

-130.56%-21.97M

-141.11%-11.54M

-130.03%-13.07M

-128.02%-10.69M

-128.43%-9.53M

26.86%-4.79M

-55.94%-5.68M

-38.60%-4.69M

-99.33%-4.17M

-43.06%-6.54M

-168.30%-3.65M

---3.38M

-16.47%-2.09M

-291.70%-4.58M

--5.34M

---1.80M

---1.17M

歸屬普通股東的淨利潤

-38.69%-6.80M

5.26%-7.28M

55.70%-5.53M

84.02%-4.91M

76.25%-7.68M

55.49%-12.48M

36.41%-20.02M

-15.12%-30.70M

-6.59%-32.34M

-20.93%-28.03M

-648.43%-31.48M

3.91%-26.66M

9.12%-30.34M

-2188.25%-23.18M

86.32%-4.21M

-19.09%-27.75M

-142.30%-33.38M

93.86%-1.01M

-22.65%-30.75M

19.44%-23.30M

375.80%78.91M

49.73%-16.51M

-9.18%-25.07M

-31.70%-28.92M

-38.54%-28.61M

-69.29%-32.84M

-33.53%-22.96M

-30.97%-21.96M

-45.67%-20.65M

-55.90%-19.40M

-84.88%-17.19M

24.49%-16.77M

35.48%-14.18M

-7.81%-12.44M

28.87%-9.30M

-107.67%-22.20M

-130.56%-21.97M

-141.11%-11.54M

-130.03%-13.07M

-128.02%-10.69M

-128.43%-9.53M

26.86%-4.79M

-55.94%-5.68M

-38.60%-4.69M

-99.33%-4.17M

-43.06%-6.54M

-168.30%-3.65M

---3.38M

-16.47%-2.09M

-291.70%-4.58M

--5.34M

---1.80M

---1.17M

基本每股收益

92.49%-0.73

84.65%-0.77

92.80%-0.59

52.30%-9.66

76.41%-5.04

55.99%-8.19

37.25%-13.17

-13.61%-20.24

-5.18%-21.37

-19.80%-18.61

-643.03%-20.98

4.56%-17.82

10.78%-20.31

-2034.83%-15.53

87.23%-2.82

-11.10%-18.67

-139.47%-22.77

94.26%-0.73

-14.66%-22.11

24.59%-16.80

361.76%57.69

52.27%-12.68

7.11%-19.28

-11.49%-22.28

-17.03%-22.04

-44.64%-26.56

-11.73%-20.76

-8.22%-19.99

-20.37%-18.83

-33.59%-18.36

-78.91%-18.58

36.92%-18.47

46.02%-15.64

9.75%-13.75

39.81%-10.38

-107.36%-29.28

-130.37%-28.98

-125.76%-15.23

-92.47%-17.25

-90.79%-14.12

-90.91%-12.58

34.97%-6.75

-54.44%-8.96

4.87%-7.40

62.49%-6.59

-37.58%-10.37

-165.98%-5.80

---7.78

-493.27%-17.57

-291.71%-7.54

--8.80

---2.96

---1.92

稀釋每股收益

92.49%-0.73

84.65%-0.77

92.80%-0.59

52.30%-9.66

76.41%-5.04

55.99%-8.19

37.25%-13.17

-13.61%-20.24

-5.18%-21.37

-19.80%-18.61

-643.03%-20.98

4.56%-17.82

10.78%-20.31

-2034.83%-15.53

87.23%-2.82

-11.10%-18.67

-141.08%-22.77

94.26%-0.73

-14.66%-22.11

24.59%-16.80

351.51%55.43

52.27%-12.68

7.11%-19.28

-11.49%-22.28

-17.03%-22.04

-44.64%-26.56

-11.73%-20.76

-8.22%-19.99

-20.37%-18.83

-33.59%-18.36

-78.91%-18.58

36.92%-18.47

46.02%-15.64

9.75%-13.75

39.81%-10.38

-107.36%-29.28

-130.37%-28.98

-125.76%-15.23

-92.47%-17.25

-90.79%-14.12

-90.91%-12.58

34.97%-6.75

-54.44%-8.96

4.87%-7.40

62.49%-6.59

-37.58%-10.37

-165.98%-5.80

---7.78

-493.27%-17.57

-291.71%-7.54

--8.80

---2.96

---1.92

每股派息

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 Tvardi Therapeutics Ord Shs 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 TVRD 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

Tvardi Therapeutics Ord Shs 全年的淨利潤是多少？



Tvardi Therapeutics Ord Shs 2025 財年淨利潤為 -18.21M。

Tvardi Therapeutics Ord Shs 上一季度的淨利潤是多少？



Tvardi Therapeutics Ord Shs 最近一個季度的淨利潤為 -6.80M。

Tvardi Therapeutics Ord Shs 年度營業利潤是多少？



Tvardi Therapeutics Ord Shs 2025 財年的營業利潤為 -26.75M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。